Capricorn Fund Managers’s Jazz Pharmaceuticals JAZZ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-6,100
Closed -$1.47M – 162
2026
Q2
$1.47M Buy
+6,100
New +$1.34M 0.12% 129
2026
Q1
– Sell
-10,000
Closed -$1.7M – 131
2025
Q4
$1.7M Buy
+10,000
New +$1.53M 0.41% 60

Other funds holding JAZZ

Capricorn Fund Managers's JAZZ Position: Q3 2026 in Review

Capricorn Fund Managers sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2026, closing a stake of 6,100 shares — an estimated $1.47M sold.

Capricorn Fund Managers first reported a position in JAZZ in Q4 2025 and held it in 2 quarters. The position peaked at $1.7M in Q4 2025. 669 funds tracked by Wall St. Rank hold JAZZ as of Q3 2026.

  • Capricorn Fund Managers reported no remaining Jazz Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • Capricorn Fund Managers sold 6,100 Jazz Pharmaceuticals shares in Q3 2026, an estimated $1.47M.
  • Capricorn Fund Managers first reported a position in Jazz Pharmaceuticals in Q4 2025 and held it in 2 quarters.
  • Capricorn Fund Managers's Jazz Pharmaceuticals position peaked at $1.7M in Q4 2025.
  • 669 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2026.

Based on Capricorn Fund Managers's 13F filing for Q3 2026, filed 3 Nov 2026.